Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

The AI model accurately classifies Alopecia Areata with 96.94% accuracy.

Certain gene variations may increase the risk of hair loss in Egyptians.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

CT60 polymorphism might increase the risk of Alopecia Areata.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

ALUDWIG can help standardize female hair loss assessment from a single image.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Alopecia areata greatly affects quality of life, needing psychological support.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

AI in heart scans improves diagnosis and treatment but has risks like misdiagnosis and high costs.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

CCCA affects Black men too, with a genetic link found in the PADI3 gene.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Hair loss in young men in Central India is linked to severe heart disease.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.